Skip to content

Treatment of knee osteoarthritis with small needle knife: a randomized controlled trial

Treatment of knee osteoarthritis with small needle knife: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033047
Enrollment
Unknown
Registered
2020-05-18
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of knee

Interventions

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the stage I, II, III of Kellgren-Lawrecne's radiological diagnostic criteria; 2. KAS pain VAS score >= 4 points; 3. The age is between 40-70 years old, regardless of gender; 4. Those who have not taken other related treatment drugs or adopted related treatment measures within 2 weeks; 5. Participate voluntarily, sign the informed consent form, be willing to accept the trial, and follow the random grouping.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or breastfeeding, or who have a pregnancy plan during the trial; 2. Patients with severely life-threatening cardiovascular and cerebrovascular diseases, liver, kidney, hematopoietic system and other diseases or infectious diseases, who are unable to complete or are not suitable for related treatment and examination; 3. Patients with local infection, ulceration, vascular nerve injury or deep abscess in the knee; 4. Patients who have a history of severe knee trauma, or have undergone surgery or arthroscopy treatment; 5. Patients with other bone diseases such as tuberculosis, tumors, rheumatism, rheumatoid arthritis, gouty arthritis and other bone diseases that are not osteoarthritis or knee pain caused by other diseases; 6. Patients who have received oral hormonal drugs or knee closure therapy and other interventions within 1 month; or patients who have participated in other clinical trials within 3 months; 7. People who are allergic to the medical devices involved in this trial; contraindications to the use of indomethacin plaster, such as those with a history of allergy to indomethacin, those with liver and kidney dysfunction (alanine aminotransferase (ALT), aspart The amino acid transaminase (AST) is more than 2 times the normal value, and the blood creatinine (cr) is more than the normal value). Patients who have induced asthma, urticaria or allergic reactions after taking aspirin or other non-steroidal anti-inflammatory drugs may have nonsteroidal Patients with a history of gastrointestinal bleeding or perforation after anti-inflammatory drugs, patients with active gastrointestinal ulcer bleeding, or patients with previous recurrent ulcers / bleeds, patients with severe heart failure, perioperative coronary artery bypass surgery, etc .; 8. Patients with bleeding tendency, such as long-term use of anticoagulants such as warfarin and aspirin; 9. Those who have a history of sedative hypnotics, opioid analgesics and alcohol abuse; 10. Patients with cognitive impairment, or language communication impairment, unable to express accurately.

Design outcomes

Primary

MeasureTime frame
WOMAC knee osteoarthritis score;

Secondary

MeasureTime frame
Patient pain score (VAS);Patient's knee X-ray examination;Patient's knee musculoskeletal ultrasound;Patient's plantar pressure test;Patient's knee circumference measurement;Patient's knee mobility measurement;

Countries

China

Contacts

Public ContactZheng Liang

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

gztcmzhengliang@163.com+86 13802533166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026